FDA Delays Popular Nicotine Pouches Over Youth Risks
Popular nicotine pouches like Zyn and Velo remain unapproved in the US despite FDA fast-track. Agency hesitates due to rising youth use and addiction concerns.
/ 2 items
Popular nicotine pouches like Zyn and Velo remain unapproved in the US despite FDA fast-track. Agency hesitates due to rising youth use and addiction concerns.
Philip Morris lowers 2025 operating income growth estimate to 10-11.5% due to heavy US investments in Zyn nicotine pouches, despite strong sales and raised earnings forecast.